By combining multi-omics, computational chemistry, and a zebrafish AD model, we found that AMK significantly relieved AD-like symptoms by modulating the target genes EGFR and HMOX1, which implied that AMK has anti-AD effects via inhibiting ferroptosis through alterations in EGFR and HMOX1. This evidence concerns the gene EGFR and Alzheimer disease.